Logo Image
News|Articles|July 31, 2024

C Diff Update: The Latest News and Research

Here is a review of the most up-to-date information around the infection.

There has been some interesting news, research, and even federal legislation around this healthcare-associated infection. Read the latest on Clostridioides difficile (C diff) in the updates below.

Having an Infectious Disease Provider Follow C diff Patients Reduces Hospital Admission for Recurrence
A hospital CDI intervention program that supported patients via an ID specialist demonstrated clinical benefits compared to another hospital where patients were followed by providers of any specialty.

Making C diff a Nationally Notifiable Infectious Disease and Condition
A bill in the House of Representatives was just introduced with the advocacy of the Peggy Lillis Foundation in hopes of bringing more recognition and research to the healthcare-associated infection.

Are Probiotics Beneficial to Pediatric Population During Antibiotic Treatment?
A secondary analysis of a randomized trial points to limited benefits on the microbiota.

Investigational C Diff Therapy Shows Favorable Microbiome Characteristics, Phase 3 Trial Planned
In additional analyses, the novel antibiotic, ibezapolstat, demonstrated favorable gut microbiome changes including increased relative proportion of Actinobacteria in ibezapolstat-treated patients with C diff Infection (CDI).

Reducing Unnecessary C diff Tests Aids in Diagnostic Stewardship, Overtreatment

A Florida hospital takes a novel approach for the healthcare-associated infection and reduced inappropriate testing by setting up guidelines.

Related to this article

View more
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Read more
Ebola and the Ongoing Tale of US Failures
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
Read more
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Read more
Measles Update: September 18, 2026
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
Read more
CDC Responds to Surge in Rabies Exposures
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
Read more
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Read more
Ceftriaxone Safety: Separating Signal From Risk
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Read more